These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 24552282)

  • 1. The effects of Psychotropic drugs On Developing brain (ePOD) study: methods and design.
    Bottelier MA; Schouw ML; Klomp A; Tamminga HG; Schrantee AG; Bouziane C; de Ruiter MB; Boer F; Ruhé HG; Denys D; Rijsman R; Lindauer RJ; Reitsma HB; Geurts HM; Reneman L
    BMC Psychiatry; 2014 Feb; 14():48. PubMed ID: 24552282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. White Matter by Diffusion MRI Following Methylphenidate Treatment: A Randomized Control Trial in Males with Attention-Deficit/Hyperactivity Disorder.
    Bouziane C; Filatova OG; Schrantee A; Caan MWA; Vos FM; Reneman L
    Radiology; 2019 Oct; 293(1):186-192. PubMed ID: 31407970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.
    Newcorn JH; Nagy P; Childress AC; Frick G; Yan B; Pliszka S
    CNS Drugs; 2017 Nov; 31(11):999-1014. PubMed ID: 28980198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylphenidate normalizes resting-state brain dysfunction in boys with attention deficit hyperactivity disorder.
    An L; Cao XH; Cao QJ; Sun L; Yang L; Zou QH; Katya R; Zang YF; Wang YF
    Neuropsychopharmacology; 2013 Jun; 38(7):1287-95. PubMed ID: 23340519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interactive effects of test-retest and methylphenidate administration on cognitive performance in youth with ADHD: A double-blind placebo-controlled crossover study.
    Horowitz I; Avirame K; Naim-Feil J; Rubinson M; Moses E; Gothelf D; Levit-Binnun N
    Psychiatry Res; 2020 Sep; 291():113056. PubMed ID: 32554183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute neuropsychological effects of methylphenidate in stimulant drug-naïve boys with ADHD II--broader executive and non-executive domains.
    Rhodes SM; Coghill DR; Matthews K
    J Child Psychol Psychiatry; 2006 Nov; 47(11):1184-94. PubMed ID: 17076758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylphenidate normalizes frontocingulate underactivation during error processing in attention-deficit/hyperactivity disorder.
    Rubia K; Halari R; Mohammad AM; Taylor E; Brammer M
    Biol Psychiatry; 2011 Aug; 70(3):255-62. PubMed ID: 21664605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do effects of methylphenidate on cognitive performance last beyond treatment? A randomized placebo-controlled trial in boys and men with ADHD.
    Tamminga HGH; Reneman L; Schrantee A; Bottelier MA; Bouziane C; Geurts HM; Groenman AP
    Eur Neuropsychopharmacol; 2021 May; 46():1-13. PubMed ID: 33735707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication-naïve children with ADHD during a rewarded continuous performance task.
    Rubia K; Halari R; Cubillo A; Mohammad AM; Brammer M; Taylor E
    Neuropharmacology; 2009 Dec; 57(7-8):640-52. PubMed ID: 19715709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical response to methylphenidate in children diagnosed with attention-deficit hyperactivity disorder and comorbid psychiatric disorders.
    Ter-Stepanian M; Grizenko N; Zappitelli M; Joober R
    Can J Psychiatry; 2010 May; 55(5):305-12. PubMed ID: 20482957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized, controlled trial of oros methylphenidate once a day in children with attention-deficit/hyperactivity disorder.
    Wolraich ML; Greenhill LL; Pelham W; Swanson J; Wilens T; Palumbo D; Atkins M; McBurnett K; Bukstein O; August G
    Pediatrics; 2001 Oct; 108(4):883-92. PubMed ID: 11581440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of methylphenidate on cognitive functions in boys with attention deficit hyperactivity disorder: Does baseline performance matter?
    Idema IME; Payne JM; Coghill D
    J Consult Clin Psychol; 2021 Jul; 89(7):615-625. PubMed ID: 34383534
    [No Abstract]   [Full Text] [Related]  

  • 13. Areas of the brain modulated by single-dose methylphenidate treatment in youth with ADHD during task-based fMRI: a systematic review.
    Czerniak SM; Sikoglu EM; King JA; Kennedy DN; Mick E; Frazier J; Moore CM
    Harv Rev Psychiatry; 2013; 21(3):151-62. PubMed ID: 23660970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Academic, behavioral, and cognitive effects of OROS® methylphenidate on older children with attention-deficit/hyperactivity disorder.
    Wigal SB; Wigal T; Schuck S; Brams M; Williamson D; Armstrong RB; Starr HL
    J Child Adolesc Psychopharmacol; 2011 Apr; 21(2):121-31. PubMed ID: 21488750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylphenidate enhances cognitive performance in adults with poor baseline capacities regardless of attention-deficit/hyperactivity disorder diagnosis.
    Agay N; Yechiam E; Carmel Z; Levkovitz Y
    J Clin Psychopharmacol; 2014 Apr; 34(2):261-5. PubMed ID: 24525641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Verbal working memory-related functional connectivity alterations in boys with attention-deficit/hyperactivity disorder and the effects of methylphenidate.
    Wu ZM; Bralten J; An L; Cao QJ; Cao XH; Sun L; Liu L; Yang L; Mennes M; Zang YF; Franke B; Hoogman M; Wang YF
    J Psychopharmacol; 2017 Aug; 31(8):1061-1069. PubMed ID: 28656805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting methylphenidate response in attention deficit hyperactivity disorder: a preliminary study.
    Johnston BA; Coghill D; Matthews K; Steele JD
    J Psychopharmacol; 2015 Jan; 29(1):24-30. PubMed ID: 25237119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylphenidate hydrochloride modified-release in adults with attention deficit hyperactivity disorder: a randomized double-blind placebo-controlled trial.
    Huss M; Ginsberg Y; Tvedten T; Arngrim T; Philipsen A; Carter K; Chen CW; Kumar V
    Adv Ther; 2014 Jan; 31(1):44-65. PubMed ID: 24371021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter, open-label trial to evaluate the quality of life in adults with ADHD treated with long-acting methylphenidate (OROS MPH): Concerta Quality of Life (CONQoL) study.
    Mattos P; Louzã MR; Palmini AL; de Oliveira IR; Rocha FL
    J Atten Disord; 2013 Jul; 17(5):444-8. PubMed ID: 22334621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder.
    Rösler M; Fischer R; Ammer R; Ose C; Retz W
    Eur Arch Psychiatry Clin Neurosci; 2009 Mar; 259(2):120-9. PubMed ID: 19165529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.